Response to: Comment on “New Alternatives for Autoimmune Disease Treatments: Physicochemical and Clinical Comparability of Biosimilar Etanercept”
Figure 1
(a) Questioned Enbrel chromatogram included in Figure 3 panel b of Miranda-Hernández et al. [2] in comparison to (b) Pfizer’s analysis by UPLC of Enbrel reference standard included in the Letter to the Editor 5047067 [1].
